Patent · US Expired

Treatment of catabolic states using authentic IGF-1 and hypocaloric amount of nutrients

US6034059A · kind A · utility

5Cited by

0References

12Claims

0Family size

Assignee

Chiron Corporation · US

Inventors

Linda Fryklund · Sollentuna, SE
Peter Gluckman · Auckland, NZ
Anna Skottner · Ekerö, SE

Key dates

Filing date	Mar 17, 1993
Grant date	Mar 7, 2000
Priority date	—
Expiry date	Mar 17, 2013

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

IGF-1 and a hypocaloric amount of nutrient are used to treat a catabolic state in a patient. The IGF-1 and nutrient can be administered simultaneously, separately or sequentially. The amounts of IGF-1 and hypocaloric amount of nutrient are effective for the treatment of the catabolic state.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.